top of page

Currently Recruitng

Clinical Trials

Currently Recruiting

3D Scans

Axsome AXS-12-301

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of AXS-12 in the Treatment of Cataplexy and Excessive Daytime Sleepiness in Subjects with Narcolepsy

KemPharm, Inc. (Zevra)– KP1077.D01

A Phase 2, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study to Determine the Safety and Efficacy of Oral SDX in Patients with Idiopathic Hypersomnia (IH)

bottom of page